Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8169427rdf:typepubmed:Citationlld:pubmed
pubmed-article:8169427lifeskim:mentionsumls-concept:C0042769lld:lifeskim
pubmed-article:8169427lifeskim:mentionsumls-concept:C0242566lld:lifeskim
pubmed-article:8169427lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8169427lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:8169427lifeskim:mentionsumls-concept:C0014508lld:lifeskim
pubmed-article:8169427lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:8169427pubmed:issue5lld:pubmed
pubmed-article:8169427pubmed:dateCreated1994-6-2lld:pubmed
pubmed-article:8169427pubmed:abstractTextIntravenous drug users (IVDUs) in Seattle (n = 213) were studied to identify the prevalence and predominant types of and risk factors for human T cell lymphotropic virus (HTLV) infection. Detailed questionnaires, serologic screening, and polymerase chain reaction analysis (for a subset) were used. Evidence of HTLV infection was found in 16.5%, of which 89% were HTLV-II. HTLV infection was significantly associated with nonwhite race, older age, more years of intravenous drug use, prior use of heroin, history of gonorrhea, history of any sexually transmitted disease, hepatitis B virus infection, and antibody to herpes simplex virus type 2 (HSV-2). By stepwise logistic regression analysis, associations persisted with race, age, hepatitis B markers, and HSV-2. Thus, the strong association of HTLV with hepatitis B, a marker for injection behavior, and the independent association with HSV-2 infection, a sexually transmitted pathogen, suggest similarities in the epidemiology of HTLV and human immunodeficiency virus infections in IVDUs.lld:pubmed
pubmed-article:8169427pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169427pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169427pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169427pubmed:languageenglld:pubmed
pubmed-article:8169427pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8169427pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8169427pubmed:statusMEDLINElld:pubmed
pubmed-article:8169427pubmed:monthMaylld:pubmed
pubmed-article:8169427pubmed:issn0022-1899lld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:SaxonAAlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:FisherL DLDlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:CalsynDDlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:ShriverKKlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:AshleyRRlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:KromeRRlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:SchwebkeJJlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:OlmsteadLLlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:KleynJJlld:pubmed
pubmed-article:8169427pubmed:authorpubmed-author:Oluoch-Mitche...lld:pubmed
pubmed-article:8169427pubmed:issnTypePrintlld:pubmed
pubmed-article:8169427pubmed:volume169lld:pubmed
pubmed-article:8169427pubmed:ownerNLMlld:pubmed
pubmed-article:8169427pubmed:authorsCompleteNlld:pubmed
pubmed-article:8169427pubmed:pagination962-7lld:pubmed
pubmed-article:8169427pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:meshHeadingpubmed-meshheading:8169427-...lld:pubmed
pubmed-article:8169427pubmed:year1994lld:pubmed
pubmed-article:8169427pubmed:articleTitlePrevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users.lld:pubmed
pubmed-article:8169427pubmed:affiliationUniversity of Washington Center for AIDS and Sexually Transmitted Diseases, Seattle.lld:pubmed
pubmed-article:8169427pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8169427pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8169427lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8169427lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8169427lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8169427lld:pubmed